AR004205A1 - Derivados de diarilalquenilaminas, composiciones farmaceuticas que las contienen y el uso de dichos derivados en la preparacion de medicamentos. - Google Patents

Derivados de diarilalquenilaminas, composiciones farmaceuticas que las contienen y el uso de dichos derivados en la preparacion de medicamentos.

Info

Publication number
AR004205A1
AR004205A1 ARP960104332A AR10433296A AR004205A1 AR 004205 A1 AR004205 A1 AR 004205A1 AR P960104332 A ARP960104332 A AR P960104332A AR 10433296 A AR10433296 A AR 10433296A AR 004205 A1 AR004205 A1 AR 004205A1
Authority
AR
Argentina
Prior art keywords
alkyl
derivatives
hydrogen
branched
same
Prior art date
Application number
ARP960104332A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR004205A1 publication Critical patent/AR004205A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Abstract

Derivados de diarialquenilaminas son agonistas y antagonistas delta potentes y selectivos de los opioides y tienen utilidad terapéutica potencialcomo analgésicos, entre otras cosas. Estos compuestos tienen la fórmula (I), en la cual, R1 yR2, que pueden ser iguales o diferentes, son cada uno hidrógeno,alquilo C1-6 lineal o ramificado, cicloalquilo C3-7, cicloalquenilo C3-7, cicloalquilalquilo C4-6, alquenilo C3-6, alquinilo C3-5, arilo, aralquilo ofuran-2 ó 3-il-alquilo, ópueden f ormar juntos un anillo de cicloalquilo C3-7 que puede estar interrumpido por oxígeno; R3 y R4, que pueden ser iguales odiferentes, son cada uno hidrógeno, alquilo C1-6 lineal o ramificado; R5 es hidroxi, alcoxi C1-6, tiol o alquiltio;R6 es un grupo -C(Z)-R8, en el cualZ es oxígeno o azufre, R8 es alquilo C1-8, alcoxi C1-8 ó NR9R10, en el cual R9 y R10, que puede ser iguales o diferentes, son hidrógeno, alquilo C1-6 linealo ramificado, cicloalquilo C3-7, cicloalquilalquilo C4-6,alquenilo C3-6, arilo o aralquilo, o R6 es un grupo (II), en el cual R11 y R12 tienen el mismosignificado que R9 y R10 o forman juntos un anillo heterocíclico opcionalmente sustituido y Z es como se ha definido anteriormente, y R7 eshidrógeno, alquilo C1-8 lineal o ramificado o halógeno. Asimismo, la presente invención describe composiciones farmacéuticas y el uso de dichos compuestos para la preparaciónde medicamentos.
ARP960104332A 1995-09-15 1996-09-12 Derivados de diarilalquenilaminas, composiciones farmaceuticas que las contienen y el uso de dichos derivados en la preparacion de medicamentos. AR004205A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001930A IT1277597B1 (it) 1995-09-15 1995-09-15 Derivati di diarilalchenilammina

Publications (1)

Publication Number Publication Date
AR004205A1 true AR004205A1 (es) 1998-11-04

Family

ID=11372254

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104332A AR004205A1 (es) 1995-09-15 1996-09-12 Derivados de diarilalquenilaminas, composiciones farmaceuticas que las contienen y el uso de dichos derivados en la preparacion de medicamentos.

Country Status (22)

Country Link
US (1) US6262104B1 (es)
EP (1) EP0873330B1 (es)
JP (1) JPH11512413A (es)
KR (1) KR19990044675A (es)
CN (1) CN1202164A (es)
AR (1) AR004205A1 (es)
AT (1) ATE240307T1 (es)
AU (1) AU706980B2 (es)
BR (1) BR9610597A (es)
CA (1) CA2232161A1 (es)
CZ (1) CZ78598A3 (es)
DE (1) DE69628200T2 (es)
ES (1) ES2195010T3 (es)
HU (1) HUP9900374A3 (es)
IL (1) IL123621A0 (es)
IT (1) IT1277597B1 (es)
NO (1) NO981131L (es)
NZ (1) NZ318774A (es)
PL (1) PL325552A1 (es)
TR (1) TR199800478T1 (es)
WO (1) WO1997010230A1 (es)
ZA (1) ZA967741B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US6103722A (en) * 1997-07-23 2000-08-15 The Medical College Of Wisconsin Research Foundation Inc. Ischemic preconditioning
ZA9811842B (en) * 1997-12-24 2000-06-23 Ortho Mcneil Pharm Inc 4-[aryl(piperidin-4-yl)]aminobenzamides.
US6436959B1 (en) 1998-12-23 2002-08-20 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)]aminobenzamides
ES2248281T3 (es) 2000-02-18 2006-03-16 Meiji Seika Kaisha, Ltd. Derivados de fenoxialquilamina utiles como agonistas del receptor opioide delta.
AU4274401A (en) * 2000-03-24 2001-10-03 Meiji Seika Kaisha Diphenylalkylamine derivatives useful as opioid delta receptor agonists
TW200526631A (en) 2003-10-07 2005-08-16 Renovis Inc Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2006023757A2 (en) * 2004-08-19 2006-03-02 University Of Virginia Patent Foundation Novel tricyclic, bicyclic, monocyclic, and acyclic amines as potent sodium channel blocking agents
CA2580694A1 (en) * 2004-09-23 2006-03-30 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080300243A1 (en) * 2005-02-28 2008-12-04 Kelly Michael G Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47628B1 (en) * 1977-07-04 1984-05-16 Astra Laekemedel Ab Substituted aralkyl amines and amino-aryl alkenes having therapeutic activity
YU44821B (en) 1982-02-04 1991-02-28 Wellcome Found Process for obtaiing new pyridyl derivatives
US4514414A (en) * 1982-10-25 1985-04-30 Smithkline Beckman Corporation N-Substituted pyrrolidineacetic acids and their esters
US4564685A (en) * 1983-03-10 1986-01-14 Findlay John W A Diphenylmethane compounds
DE3689506D1 (de) * 1985-10-09 1994-02-17 Shell Int Research Neue Acrylsäureamide.
KR920702620A (ko) 1989-06-19 1992-10-06 엠. 피. 잭슨 암치료에 유용하며 항히스타민성 특성을 갖는 약물

Also Published As

Publication number Publication date
ITMI951930A0 (it) 1995-09-15
MX9802024A (es) 1998-08-30
NO981131L (no) 1998-03-16
ZA967741B (en) 1998-03-13
TR199800478T1 (xx) 1998-06-22
DE69628200D1 (de) 2003-06-18
ES2195010T3 (es) 2003-12-01
HUP9900374A3 (en) 1999-11-29
JPH11512413A (ja) 1999-10-26
BR9610597A (pt) 1999-07-06
EP0873330B1 (en) 2003-05-14
AU7084796A (en) 1997-04-01
IT1277597B1 (it) 1997-11-11
US6262104B1 (en) 2001-07-17
CA2232161A1 (en) 1997-03-20
NO981131D0 (no) 1998-03-13
CN1202164A (zh) 1998-12-16
PL325552A1 (en) 1998-08-03
EP0873330A1 (en) 1998-10-28
IL123621A0 (en) 1998-10-30
ATE240307T1 (de) 2003-05-15
DE69628200T2 (de) 2003-11-27
CZ78598A3 (cs) 1998-08-12
NZ318774A (en) 1998-08-26
KR19990044675A (ko) 1999-06-25
ITMI951930A1 (it) 1997-03-15
AU706980B2 (en) 1999-07-01
HUP9900374A2 (hu) 1999-06-28
WO1997010230A1 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
AR004205A1 (es) Derivados de diarilalquenilaminas, composiciones farmaceuticas que las contienen y el uso de dichos derivados en la preparacion de medicamentos.
AR035068A1 (es) Compuestos de pirimidinona, composiciones farmaceuticas que los comprenden, uso de tales compuestos en la fabricacion de medicamentos y proceso para la preparacion de dichos compuestos
AR076838A1 (es) Sulfonamidas nematocidas
AR106755A2 (es) Inhibidores pirrólicos de la proteína quinasa erk, síntesis e intermediarios de los mismos
AR013493A1 (es) COMPUESTO DE QUINOLONA, SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO Y COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE
AR063101A1 (es) Derivados de pirazina-2-carboxiamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento o profilaxis de enfermedades asociadas con la modulacion de receptores del cb2.
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
AR064524A1 (es) Derivados de n-(amino-(hetero)aril)-1h-pirrolopiridin-2-carboxamidas, su preparacion, intermediarios para su sintesis, una composicion farmaceutica que los comprende y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por los receptores de tipo trpv1.
PE20020062A1 (es) 5-AMINO-PIRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PIRIMIDINA COMO ANTAGONISTAS RECEPTORES DE ADENOSINA A2a
HUP0300693A2 (hu) Eljárás epotilon-analógok és -intermedierek előállítására
ECSP045229A (es) Piridinonas sustituidas como moduladores de la p38 map quinasa
AR050698A1 (es) Compuesto de benzazepina, composicion farmaceutica que lo comprende, su uso para la fabricacion de un medicamento y procedimiento para la preparacion de dicho compuesto
AR051753A1 (es) Metodos para preparar compuestos de indazol
ES2051729T3 (es) Composiciones espesadas acuosas para la limpieza.
AR050267A1 (es) Derivados de urea ciclicos sustituidos con heterociclo, su preparacion y su uso farmaceutico como inhibidores de quinasa
AR054182A1 (es) Derivados de piperidina y su uso como agentes antiinflamatorios. procesos de obtencion y composiciones farmaceuticas
CO5690582A2 (es) Derivados de n-tiazol-2-il-benzamida
AR054529A1 (es) Derivados de benzazepina como moduladores del receptor de 5-hidroxi-triptamina 6
AR043434A1 (es) Derivados de piperizacina acilados como agonistas del receptor de melanocortina-4. composiciones farmaceuticas y usos
AR076860A1 (es) Derivados de 7-aril- 1,2,4-triazolo[4,3-a]piridina moduladores alostericos positivos de receptores mglur2, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de trastornos neurologicos y siquiatricos.
AR055878A1 (es) Derivados de ciclopropanocarboxamida
AR058587A1 (es) Compuestos de pirrolo-1,5-naftiridinona,su uso como agentes antibacterianos, composiciones farmaceuticas que los contienen y compuestos intermediarios para preparar dichos compuestos
AR013076A1 (es) Nuevos compuestos de piperazina, un procedimiento para su preparacion y una composicion farmaceutica que los comprende
AR054857A1 (es) Derivados de n- (heteroaril)-1- heteroarilquil-1 h - indol-2- carboxamidas, su preparacion y su aplicacion en terapeutica
AR065863A1 (es) Derivados de imidazolidinona